Schedule Your Appointment Call Us 850-215-3062

 
     
   

RHEUMATOID ARTHRITIS

 

Rheumatoid arthritis is a debilitating autoimmune disease that affects around 3 million Americans. It results in inflammation involving the joints leading to chronic pain, swelling, stiffness and eventual loss of function and disability if left untreated. Rheumatoid arthritis most commonly affects people between the ages of 25-45 and those over the age of 65. Patients with RA are also at significantly increased risk of certain blood cancers and lymphoma. 


Common symptoms:
 Pain, swelling and stiffness of small joints of hands and feet
 Swollen knuckles/fingers
 Morning stiffness
 Fatigue
 Fever and weight loss
 Eye inflammation, redness and pain

 

Diagnosis:
X-rays are used to monitor joint damage over time.
Symptoms of joint swelling/stiffness involving the hands and feet as well as laboratory studies

       confirming positive antibodies in the blood. 

 

Treatment:
 Oral and intra-muscular steroids
 NSAIDS
 DMARDS (disease modifying anti-rheumatic drugs)
 Biologics (injectables)
 Physical therapy

Treatment has advanced tremendously in the past 10-15 yrs. This is an exciting time for patients suffering with RA because our goal now for them is complete remission of their disease and halting of joint damage. With new advancements in immune modifying drugs as well as continous research and new medications emerging , this is certainly a very realistic possibility. The single most important factor in minimizing joint damage and disability is early diagnosis and treatment by a rheumatologist.


OUR SPECIALTIES

Osteoarthritis
Rheumatoid Arthritis
Connective tissue diseases
Psoriatic Arthritis
Gout
Fibromyalgia
Osteoporosis
Polymyalgia Rheumatica

CONTACT INFO

Bay Arthritis Institute

2917 Hwy 77

Panama City, FL 32405

850-215-3062 phone

850-215-3024 fax

 

 

     
Home | About Us | Specialties | Resources | Recent News | Contact Us | Login

Bay Arthritis Institute © 2017

Powered byAaron Rich Digital Marketing & IT Services